High flow nasal cannula versus standard low flow nasal oxygen during flexible bronchoscopy in children: A randomized controlled trial. Issue 12 (10th September 2021)

• Record Type: Journal Article
• Authors: Sharluyan, Artur; Osona, Borja; Frontera, Guillem; Brandstrup, Kay Boris; Figuerola, Joan; Sanz‐Ruiz, Isabel; Salas, Alberto; Garrido, Beatriz; Eva, Chocano‐González; Fernandez, Andrea; Peña‐Zarza, Jose Antonio; Gil, Jose Antonio; Bover‐Bauzà, Catalina; Sailer, Sebastian
• Is Part Of: Pediatric pulmonology. Volume 56:Issue 12(2021)
• Page Start: 4001
• Page End: 4010
• Publication Date: 2021-09-10
• Subjects: bronchoscopy -- pulmonology (general) -- oxygenation and therapy; Pediatric respiratory diseases -- Periodicals; Pediatrics -- Periodicals; 618.922
• DOI: 10.1002/ppul.25655
• Languages: English
• ISSNs: 8755-6863

Abstract

Abstract: Background: Hypoxemia is the most frequent complication of fiberoptic bronchoscopy (FB) in children. Guidelines recommend oxygen supplementation and conventional nasal prongs (NC) are used for this purpose. The aim of this study was to evaluate if the use of high‐flow nasal cannula therapy (HFNC) in children undergoing FB result in a lower incidence of hypoxemia than standard oxygen administration. Methods: Patients aged 1 month–16 years undergoing elective FB were included in a prospective randomized controlled, nonblinded, single‐center clinical trial and randomly assigned to receive oxygen via NC or HFNC. Patients' baseline characteristics were recorded pre‐bronchoscopy. The primary outcome was oxygen desaturation during the procedure defined as saturation less than 94%. Results: An intention to treat analysis for 53 patients receiving NC and 51 receiving HFNC, showed HFNC patients were less likely to have hypoxemia than were NC patients ( p = .011), with an absolute risk reduction of 0.27 (95% confidence interval [CI]: 0.08–0.45) and a number needed to treat of 3.75 (95% CI: 2.22–12.04). Moderate hypoxemia (SpO2 ≥ 90% and <94%, and <60 s) was observed significantly less often with HFNC than with NC ( p = .012). Severe hypoxemia (SpO2 < 90% and >30 s) was not different between groups. Patients undergoing bronchoalveolar lavage (BAL) presented fewer desaturations with HFNC ( p = .0003). Conclusions: HFNC offers optimized oxygenation during elective FB with a significant reduction in desaturations and can be considered for oxygen administration, especially when BAL is performed.